Therapeutic potential of adipose-derived mesenchymal stem/stromal cells conditioned medium versus adipose-derived mesenchymal stem/stromal cells on treatment of polycystic ovary In-vivo.
Abou-El-Naga A., Elarby NY., Sobh MA., Mutawa G.
Animal Study on Type 2 Diabetes, published in Tissue Cell (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Tissue Cell (2026)
- Country
- Scotland
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42202461
- DOI
- 10.1016/j.tice.2026.103634
Abstract (original English)
Polycystic ovary syndrome (PCOS) is a prevalent endocrine and metabolic disorder characterized by ovulatory dysfunction and insulin resistance. Adipose tissue-derived Mesenchymal stem/stromal cell (Ad-derived MSCs)-based therapies have shown promising regenerative effects in PCOS models. However, most cell-free therapeutic investigations have primarily focused on MSC-derived exosomes, whereas the therapeutic potential of the complete conditioned medium (CM), which contains a broader spectrum of secreted bioactive factors, remains underexplored. Therefore, this study aimed to compare the therapeutic efficacy of Ad-derived MSCs and their CM in a letrozole-induced PCOS female rat (four groups: control, PCOS, Ad-derived MSCs-treated, and Ad-derived MSCs-CM-treated). Hormonal profiling, reproductive performance, and estrous cyclicity were monitored. Metabolic parameters comprised the insulin resistance index (HOMA-IR) and lipid profile markers. Glutathione and malondialdehyde as oxidative stress biomarkers, Annexin V/PI and Caspase-3 as apoptotic markers, and inflammatory mediators were evaluated alongside histological and immunohistochemical examination of ovarian and uterine tissues. PCOS induction produced endocrine imbalance, insulin resistance, dyslipidemia, oxidative stress, and increased apoptosis with marked ovarian and uterine structural alterations. Both Ad-derived MSCs an
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
The Influence of GLP-1 Agonists on Human Mesenchymal Stem Cells: A Systematic Review
Systematic Review on Type 2 Diabetes, published in Stem Cell Rev Rep (2026) — summary generated from the PubMed abstract.
- 2026
Stem Cell Rev Rep2 citations - Level ASystematic ReviewEurope PMC
Dedifferentiation of Mature Adipocytes and Their Future Potential for Regenerative Medicine Applications
Systematic Review on Type 2 Diabetes, Chronic Wound, published in Biomedicines (2026) — summary generated from the PubMed abstract.
- 2026
Biomedicines - Level ASystematic ReviewEurope PMC
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis
Systematic Review on Type 2 Diabetes, Chronic Inflammation, published in Food Sci Nutr (2026) — summary generated from the PubMed abstract.
- 2026
Food Sci Nutr - Level AMeta-analysisEurope PMC
Autologous and allogeneic mesenchymal stem cell-based therapies for diabetes mellitus: A systematic review and meta-analysis
Meta-analysis on Type 2 Diabetes, Immune Modulation, published in World J Stem Cells (2025) — summary generated from the PubMed abstract.
- 2025
World J Stem Cells1 citations - Level ASystematic ReviewPubMed
Systematic Review: Exosomes as Molecular Messengers in the Development of Obesity-Related Complications in Children.
Systematic Review on Type 2 Diabetes, published in Curr Issues Mol Biol (2025) — summary generated from the PubMed abstract.
- 2025
Curr Issues Mol Biol - Level AMeta-analysisEurope PMC
Thiamine as a putative natural modulator of PPARγ: exploring a nutrient-based approach for type 2 diabetes
Meta-analysis on Type 2 Diabetes, published in Front Pharmacol (2025) — summary generated from the PubMed abstract.
- 2025
Front Pharmacol